Page 8 - Amrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amrx Today - Breaking & Trending Today

Amneal Pharmaceuticals (NYSE:AMRX) Issues FY 2023 Earnings Guidance

Amneal Pharmaceuticals (NYSE:AMRX – Get Free Report) issued an update on its FY 2023 earnings guidance on Friday morning. The company provided EPS guidance of $0.45-$0.55 for the period, compared to the consensus EPS estimate of $0.47. The company issued revenue guidance of $2.30 billion-$2.40 billion, compared to the consensus revenue estimate of $2.32 billion. […] ....

Piper Sandler , Amneal Pharmaceuticals Price Performance , Amneal Pharmaceuticals Company Profile , Neuberger Berman Group , Amneal Pharmaceuticals Inc , Blackrock Inc , Vanguard Group Inc , Amneal Pharmaceuticals , Institutional Trading Of Amneal Pharmaceuticals , Morgan Stanley , Millennium Management , News Ratings For Amneal Pharmaceuticals Daily , Get Free Report , Moderate Buy , Berman Group , Amneal Pharmaceuticals Daily , Nyse Amrx ,

Amneal Pharmaceuticals (NYSE:AMRX) Given New $5.00 Price Target at Barclays

Amneal Pharmaceuticals (NYSE:AMRX – Get Free Report) had its price objective lifted by investment analysts at Barclays from $4.00 to $5.00 in a research report issued on Friday, FlyOnTheWall reports. Barclays‘s price objective suggests a potential upside of 21.65% from the stock’s current price. Other research analysts also recently issued reports about the company. Piper […] ....

United States , Piper Sandler , Grantham Mayo Van Otterloo Co , American Century Companies Inc , Amneal Pharmaceuticals , Hedge Funds Weigh In On Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Stock , News Ratings For Amneal Pharmaceuticals Daily , Pricet Rowe Associates Inc , Get Free Report , Century Companies , Montreal Can , Mayo Van Otterloo , Gate Manager , Pricet Rowe Associates , Amneal Pharmaceuticals Daily , Nyse Amrx , Boost Price Target , Barclays Plc ,

Amneal Pharmaceuticals (NYSE:AMRX) Price Target Increased to $5.00 by Analysts at Barclays

Amneal Pharmaceuticals (NYSE:AMRX – Get Free Report) had its price objective raised by stock analysts at Barclays from $4.00 to $5.00 in a research report issued on Friday, FlyOnTheWall reports. Barclays‘s price objective indicates a potential upside of 21.65% from the stock’s current price. A number of other brokerages have also weighed in on AMRX. […] ....

Piper Sandler , York Mellon Corp , Amneal Pharmaceuticals Trading , Panagora Asset Management Inc , News Ratings For Amneal Pharmaceuticals Daily , Metlife Investment Management , Amneal Pharmaceuticals , Institutional Trading Of Amneal Pharmaceuticals , Blackrock Inc , Swiss National Bank , Amneal Pharmaceuticals Company Profile , Amneal Pharmaceuticals Inc , Get Free Report , National Bank , New York Mellon Corp , Life Investment Management , Asset Management , Amneal Pharmaceuticals Daily , Nyse Amrx , Boost Price Target , Barclays Plc ,

Amneal Pharmaceuticals (NYSE:AMRX) Stock Price Down 4.9%

Amneal Pharmaceuticals, Inc. (NYSE:AMRX – Get Free Report)’s stock price fell 4.9% on Tuesday . The company traded as low as $3.06 and last traded at $3.12. 307,595 shares changed hands during mid-day trading, a decline of 70% from the average session volume of 1,038,998 shares. The stock had previously closed at $3.28. Analyst Ratings […] ....

United States , Piper Sandler , Jpmorgan Chase Co , Institutional Trading Of Amneal Pharmaceuticals , Squarepoint Ops , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals , Ameriprise Financial Inc , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Trading Down , Get Free Report , Pharmaceuticals Trading Down , Retirement System , Street Corp , Amneal Pharmaceuticals Daily , Nyse Amrx ,